Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,449
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,872
Class I recallsReasonable probability of serious health consequences
24,509
Class II recallsTemporary or medically reversible health consequences
2,932
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,096 recalls
Most affected stateHawaii 200 recalls mention this state

Advertisement

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,956 recalls have been announced year to date.
  • Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
  • The highest complete period was Jun 2026 (300).
  • Nov 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2

Showing 12,721–12,740 of 21,307 recalls

FDA Recall TerminatedTerminated: January 20, 2021Historical recordClass III

Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-285-37

by InvaGen Pharmaceuticals, Inc.

Reason
Failed impurities/degradation specifications: Failure to water content and impurity
Published
April 18, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 24, 2019Historical recordClass II

Zhong Hua Jiu (menthol 1%) Patch, Distributed by United Pacific Company, UPC 6 924938 100226, NDC 53614-001-02

by United Pacific Co Ltd

Reason
CGMP Deviations: the product was produced with substandard GMP manufacturing processes.
Published
April 18, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 15, 2020Historical recordClass II

Conzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3%, 1.5 oz. tube, OTC, Manufactured for Elrose Labs, Inc., Sanford, FL

by Elroselabs Inc.

Reason
cGMP Deviations
Published
April 18, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 15, 2020Historical recordClass II

Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.

by Elroselabs Inc.

Reason
cGMP Deviations
Published
April 18, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 15, 2020Historical recordClass II

Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06

by Elroselabs Inc.

Reason
cGMP Deviations
Published
April 18, 2018
Distribution
Nationwide

View recall →

FDA Recall United States CompletedHistorical recordClass II

Poppies International INC

Product
GFS Belgian Mini Chocolate Topped Eclairs, Keep Frozen, Net…
Reason
Products may be contaminated with Listeria monocytogenes
Published
April 18, 2018
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 24, 2018Historical recordClass III

Pepsi Cola Bottling Company

Product
Diet Pepsi; NOW ASPARTAME FREE; 6 PACK; 16 OZ BOTTLES; 6-16…
Reason
Case labeling (shrink-wrap labeling) for Diet Pepsi 6 packs (6-16oz bottles) may indicate that the product is "Now Aspartame Free" when the product actually contains aspartame. The individual 16 oz. bottles have aspartame declared in the ingredient statements. The outer wrapping has the incorrect/misdeclared "Now Aspartame Free" declaration.
Published
April 18, 2018
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: October 6, 2023Historical recordClass III

Bestco, Inc.

Product
Signature Care Calcium Chews; Dietary Supplement; 500 mg Cal…
Reason
A packaging revision and lack of revision to the corresponding packaging batch record caused the labeling for the firm's Signature Care brand Calcium Chews dietary supplement to declare a higher level of Vitamin D than the product actually contained. The bag declares 25 mcg (1000 IU) of Vitamin D. The product actually contains 12.5 mcg (500 IU) of Vitamin D.
Published
April 18, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 15, 2021Historical recordClass III

buPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDC 69097-878-07) bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788

by InvaGen Pharmaceuticals, Inc.

Reason
Failed Dissolution Specifications; during stability testing
Published
April 11, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 15, 2021Historical recordClass III

buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788 --- NDC 69097-877-03

by InvaGen Pharmaceuticals, Inc.

Reason
Failed Dissolution Specifications; during stability testing
Published
April 11, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 11, 2020Historical recordClass III

Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.

by Mayne Pharma Inc

Reason
Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
Published
April 11, 2018
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: April 12, 2018Historical recordClass I

First Source, LLC

Product
Wegmans Yogurt Raisins, 9 OZ (255g), in a plastic tub, UPC:…
Reason
Product contains undeclared peanuts.
Published
April 11, 2018
Distribution
Wegmans Stores in MA, MD, NJ, NY, PA and…

View recall →

FDA Recall United States TerminatedTerminated: March 11, 2019Historical recordClass I

Natural Grocers by Vitamin Cottage

Product
Natural Grocers Organic Coconut Smiles, 10 oz. plastic resea…
Reason
Coconut smiles product tested positive for Salmonella.
Published
April 11, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 22, 2020Historical recordClass III

24-HOUR Oral Care q4 Kit with Ballard* Technology, containing 2 Toothbrush Packs with CHG Solution, Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cup (NDC 50383-720-15), Rx Only, Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701; Kit Manufactured by Halyard Health, Inc., 5405 Windward Parkway, Alpharetta, GA 30004; Distributed in the USA by Halyard Sales, LLC, Alpharetta, GA 30004, Product 97014.

by Akorn, Inc.

Reason
Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.
Published
April 4, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 22, 2020Historical recordClass III

24-HOUR Oral Care q2 Kit with Ballard* Technology, containing 2 Toothbrush Packs with CHG Solution, Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cup (NDC 50383-720-15), Rx Only, Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701; Kit Manufactured by Halyard Health, Inc., 5405 Windward Parkway, Alpharetta, GA 30004; Distributed in the USA by Halyard Sales, LLC, Alpharetta, GA 30004, Product 97012.

by Akorn, Inc.

Reason
Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.
Published
April 4, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 22, 2020Historical recordClass III

Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cups (NDC 50383-720-15) packaged in 100-count (10 x 10) cups per case pack (NDC 50383-720-18 or 50383-720-19), Rx Only, Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701.

by Akorn, Inc.

Reason
Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.
Published
April 4, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 3, 2020Historical recordClass II

Fosphenytoin Sodium Injection, USP 500 mg PE*/10 mL, Made in India. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807, NDC 70121-1390-1

by Amneal Pharmaceuticals

Reason
Presence of particulate matter
Published
April 4, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: July 16, 2020Historical recordClass II

Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapolis, MN 55427. NDC: 0574-2067-27

by Paddock Laboratories, LLC.

Reason
Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.
Published
April 4, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 16, 2019Historical recordClass III

Indomethacin Capsules USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-302-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
Labeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day." rather than the correct usual adult dosage of "One capsule 2 or 3 times a day.
Published
April 4, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 10, 2020Historical recordClass III

Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10

by Renaissance Lakewood, LLC

Reason
Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
Published
April 4, 2018
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.